A 62-year-old man with type 2 diabetes and eGFR 35 mL/min/1.73m² is scheduled for coronary angiography. Which feature best distinguishes iso-osmolar contrast media (IOCM) from low-osmolality contrast media (LOCM) in the context of contrast-induced nephropathy (CIN) risk?

Explanation

## IOCM vs LOCM: The Osmolality Paradox in CIN Prevention ### Definition and Osmolality **Key Point:** Iso-osmolar contrast media (IOCM, e.g. ioversol, osmolality 290 mOsm/kg) has osmolality equal to plasma, whereas LOCM (e.g. iopamidol, osmolality 600–850 mOsm/kg) remains hyperosmolar but less so than HOCM (> 1400 mOsm/kg). ### Clinical Evidence: The Surprising Finding ```mermaid flowchart TD A["Contrast Media Selection<br/>in Renal Impairment"]:::outcome A --> B{"Osmolality Difference?"}:::decision B -->|"IOCM = 290 mOsm/kg<br/>LOCM = 600-850 mOsm/kg"|C["Theoretical advantage<br/>for IOCM"]:::action A --> D{"Clinical CIN Trials?"}:::decision D -->|"PRESERVE trial (2018)<br/>PRESERVE-CKD (2020)"|E["NO significant difference<br/>in CIN incidence"]:::outcome E --> F["Both IOCM and LOCM<br/>acceptable if hydration<br/>+ N-acetylcysteine given"]:::action ``` | Contrast Type | Osmolality | CIN Risk (Hydrated Patients) | CIN Risk (High-Risk Patients) | |---------------|-----------|------------------------------|------------------------------| | **IOCM** | 290 mOsm/kg (iso-osmolar) | 3–5% | 5–10% | | **LOCM** | 600–850 mOsm/kg (low-osmolar) | 3–5% | 5–10% | | **HOCM** | > 1400 mOsm/kg | 10–15% | 15–25% | **High-Yield:** Despite the theoretical osmolality advantage, major randomized trials (PRESERVE, PRESERVE-CKD) found NO significant difference in CIN incidence between IOCM and LOCM when adequate hydration and supportive measures are provided. The osmolality difference alone does not translate to clinical superiority. ### Clinical Pearl **Clinical Pearl:** In this patient (eGFR 35, diabetic), the best strategy is adequate IV hydration (0.9% saline), use of either IOCM or LOCM (no clear winner), and consideration of N-acetylcysteine. The osmolality difference between IOCM and LOCM is NOT the key discriminator in preventing CIN — hydration status and total contrast volume are. **Warning:** Do NOT assume IOCM is automatically superior to LOCM in renal impairment. Current guidelines do not mandate IOCM over LOCM if hydration is optimized. [cite:Harrison 21e Ch 474; KDIGO Cardiovascular Disease in CKD 2012]